We also analyzed the gene expression profiles of other cancers and found that the PKM2 mRNA levels were also elevated in breast cancer [15], lung cancer [16], colon cancer [17] (Fig. 1A), gastric cancer [18], and bladder cancer [19] (data not shown). This evidence concerns the gene PKM and lung carcinoma.